Comparison of CD4 counts with mycophenolate mofetil versus methotrexate from the First-line Antimetabolites as Steroid-sparing Treatment (FAST) Uveitis Trial

PURPOSE: Sub-analysis of the FAST Trial comparing change in CD4 (∆CD4) from baseline through 12 months in uveitis patients treated with mycophenolate mofetil (MMF) and methotrexate (MTX). METHODS: Patients were randomly allocated to 1.5g twice daily MMF or 25mg weekly MTX. Individuals with CD4 count...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Ocul Immunol Inflamm
Main Authors: Kong, Christina L., Kelly, Nicole K, Sundararajan, Miel, Rathinam, S.R, Gonzales, John A., Thundikandy, Radhika, Vedhanayaki, Rajesh, Kanakath, Anuradha, Murugan, Bala, Doan, Thuy, Goldstein, Debra, Al-Dhibi, Hassan A., Acharya, Nisha R.
Format: Artigo
Jezik:Inglês
Izdano: 2022
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC7876156/
https://ncbi.nlm.nih.gov/pubmed/32779952
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/09273948.2020.1774906
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki